ACADEMIC + INDUSTRY ADVISORS
Carl Novina, MD, PhD
Associate Professor, Dana-Farber Cancer Institute & Harvard Medical School
Associate Member, Broad Institute of Harvard/MIT
Fred Mermelstein, PhD
Entrepreneur in Residence, Dana-Farber Cancer Institute
Founder and Partner of Ascentia Asset Management, Inc.
Founder and Former CEO/President of Javelin Pharmaceuticals, Inc.
Robert Distel, PhD
Special Advisor for Technology Development at Dana-Farber
Former Director of Dana-Farber Translational Research Laboratory
CEO, Courage Therapeutics
Founder & CTO, Graticule, Inc.
Madalyn McFarland - Director (current)
PhD Candidate, Biological Sciences in Public Health Program, Harvard University
Jeff Haswell - Director (current)
PhD Candidate, Biological & Biomedical Sciences Program, Harvard University
Kelly Girskis - Director (2016-2018)
Associate, SVB Leerink
Alex Simon, PhD - Founder (2014)
Intern, Corporate Development, Genome Canada